Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 31 for “"Death Receptor-5"”.

  1. Characterization Of The Interactions Of Calmodulin With Fas And Death Receptor-5, And Determine The Role Of Calmodulin - Death Receptor-5 Binding In Disc Formation In Breast Cancer.

    … Fas and DR-5 mediated apoptosis. The Fas receptor apoptotic pathway has been well characterized in cholangiocarcinoma; however, targeting Fas for anti-cancer therapy has shown hepatotoxicity in vivo. Thus, in vitro studies with breast cancer will focus on the DR-5 mediated apoptotic …

    uab Repository record for Characterization Of The Interactions Of Calmodulin With Fas And Death Receptor-5, And Determine The Role Of Calmodulin - Death Receptor-5 Binding In Disc Formation In Breast Cancer. (opens in a new tab)

  2. Role Of Calmodulin In Death Receptor 5-Mediated Apoptosis In Breast Cancer

    Drug resistant estrogen receptor positive (ER-positive) and triple-negative (TN) breast cancers, are prolific breast cancers with poor clinical outcome. TRA-8 is a death receptor-5 (DR5) specific agonistic antibody with tumoricidal activity in vitro and in vivo, without inducing normal hepatocyte …

    uab Repository record for Role Of Calmodulin In Death Receptor 5-Mediated Apoptosis In Breast Cancer (opens in a new tab)

  3. The Death Receptor 5 regulates 5-FU-induced apoptosis via the p38 SAPK pathway

    … through p53-dependent upregulation of TRAILreceptor 2 (TRAIL-R2) also known as Death Receptor 5 (DR5), leading to a partial activation of the receptor independent of its ligand TRAIL. This activation triggers non-canonical signalling including the p38 MAPK pathway, which is absent or …

    essex Download PDF for The Death Receptor 5 regulates 5-FU-induced apoptosis via the p38 SAPK pathway (opens in a new tab)

  4. Regulation of cytotoxic drug-induced apoptosis by death receptor 5 in human colon cancer cells

    … drugs such as 5-FU are thought to trigger cell death via the intrinsic apoptosis pathway which involves caspase-9 activation as one of the initiating molecular events. However, our group recently found the new apoptotic pathways which are involved in 5-FU-induced apoptosisin which caspase-8 is …

    essex Download PDF for Regulation of cytotoxic drug-induced apoptosis by death receptor 5 in human colon cancer cells (opens in a new tab)

  5. Synthetic Methodologies for Molecular Imaging: Synthesis, Cyclization and In Vitro Binding Study of Death Receptor 5 Targeted Peptides

    … anticancer ligand that can biologically bind to Death Receptor 5 (DR5). Studies have showed that colorectal cancers have significant DR5 upregulation. Except in oncology, liver fibrosis is also relevant to TRAIL, which is a common chronic liver disease that will lead to liver cirrhosis and …

    jhu Repository record for Synthetic Methodologies for Molecular Imaging: Synthesis, Cyclization and In Vitro Binding Study of Death Receptor 5 Targeted Peptides (opens in a new tab)

  6. Sensitization of glioma to death receptor 5-mediated apoptosis through genotoxic stress and cell cycle disruption: A study of mechanism

    Our laboratory reported that a combination of ionizing radiation (IR) or temozolomide (Tmz), a DNA methylating agent clinically approved against glioblastoma multiforme (GBM), a type of human brain cancer, and TRA-8, an anti-DR5 monoclonal antibody produced synergistic cytotoxicity in GBM cells in …

    uab Repository record for Sensitization of glioma to death receptor 5-mediated apoptosis through genotoxic stress and cell cycle disruption: A study of mechanism (opens in a new tab)

  7. Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/ß-Catenin Signaling In Basal-Like Breast Cancer Stem Cells

    … antibody that binds specifically to TRAIL death receptor 5, preferentially induces apoptosis in BLBC subtype cells; however it is unknown if TRA-8 is also cytotoxic to the CSC population. Moreover, some BLBC cell lines are resistant to TRA-8, and overcoming resistance is critical for …

    uab Repository record for Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/ß-Catenin Signaling In Basal-Like Breast Cancer Stem Cells (opens in a new tab)

  8. The Use of Molecular Imaging to Evaluate te Efficacy of Treatments for Metastatic Breast Cancer

    … imaging to evaluate the efficacy of Death Receptor 5 agonist therapy for the treatment of breast cancer metastasis, predominately to the skeleton, in an athymic nude mouse model. Initially, we determined that bioluminescence imaging was the most ideal technology for studying secondary …

    uab Repository record for The Use of Molecular Imaging to Evaluate te Efficacy of Treatments for Metastatic Breast Cancer (opens in a new tab)

  9. MOLECULAR IMAGING OF INFLAMMATION-RELATED BIOMARKERS IN CANCER, FIBROSIS, AND NEURODEGENERATIVE DISEASE

    … disease (nicotinic acetylcholine receptors and soluble epoxide hydrolase), and fibrosis (death receptor 5). We aim to show the feasibility and importance of these efforts in the following 6 chapters. In chapter 1, we provide an introduction to molecular imaging, discuss …

    jhu Repository record for MOLECULAR IMAGING OF INFLAMMATION-RELATED BIOMARKERS IN CANCER, FIBROSIS, AND NEURODEGENERATIVE DISEASE (opens in a new tab)

  10. Integrating Protein Engineering and Genomics for Cancer Therapy

    … cancer resistance to protein agonists of death receptor 5 (DR5), a key upregulated marker in colorectal cancer (CRC). Over the past decade, various DR5 agonists have shown poor clinical efficacy, including both engineered antibodies and TRAIL, the natural ligand for this receptor. …

    duke Repository record for Integrating Protein Engineering and Genomics for Cancer Therapy (opens in a new tab)

  11. MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME

    … MSC (MSC-TRAIL) and CBX enhanced glioma cell death, especially in two primary human glioma isolates that are marginally sensitive to TRAIL. CBX enhanced TRAIL-induced apoptosis through CHOP-mediated upregulation of death receptor 5 and downregulation of anti-apoptotic Bcl-2. CBX also blocked …

    nus Repository record for MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME (opens in a new tab) Download file for MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME (opens in a new tab)

  12. Effect Of The Combined Treatment Of Tra-8, An Agonistic Dr5 Antibody, And Tamoxifen On Breast Cancer Cells

    … women and is the second leading cause of cancer death in the United States. The disease affects an estimated 1.3 million women annually worldwide. Some breast cancer cells have developed mechanisms of circumventing drug treatment. Clinical needs for breast cancer cell sensitization to anti-cancer …

    uab Repository record for Effect Of The Combined Treatment Of Tra-8, An Agonistic Dr5 Antibody, And Tamoxifen On Breast Cancer Cells (opens in a new tab)

  13. Development of novel antibody-targeted nanoparticle strategies for treatment of pancreatic cancer

    … the TNF-related apoptosisinducing ligand (TRAIL) receptor 2/ death receptor-5 (DR5) pathway using the monoclonal antibody conatumumab (AMG 655). However, the results of these clinical trials proved disappointing with no survival advantage being observed. Subsequent literature has suggested that …

    qu-belfast Repository record for Development of novel antibody-targeted nanoparticle strategies for treatment of pancreatic cancer (opens in a new tab) Download PDF for Development of novel antibody-targeted nanoparticle strategies for treatment of pancreatic cancer (opens in a new tab)

  14. Targeting Pathological Protein Interactions in Drug Discovery

    … platform that detects structural changes in death receptor 5 (DR5), a membrane protein which regulates apoptosis. In this chapter we have identified small-molecules which modulate DR5 signaling and sensitize TRAIL-resistant cancer cells to TRAIL-induced apoptosis. In chapter 3, the same HTS …

    umn Repository record for Targeting Pathological Protein Interactions in Drug Discovery (opens in a new tab)

  15. Targeting triple negative human breast cancer with omega-3 docosahexaenoic acid (DHA) and tocotrienol

    … binding protein) homologous protein (CHOP)/death receptor-5 (DR5) pro-apoptotic signaling involving caspases-8 and 9. DHA eliminated TICs as measured by elimination of aldehyde dehydrogenase active (ALDH⁺) population and inhibition of mammosphere formation. DHA eliminated TICs via …

    texas Repository record for Targeting triple negative human breast cancer with omega-3 docosahexaenoic acid (DHA) and tocotrienol (opens in a new tab)

  16. Extending the scope of covalent peptide-protein conjugation: from purification to expanded nanoassembly

    … assemblies. An agonistic nanobody against Death Receptor 5 was multimerised through SpyCatcher002-oligomers and showed a stoichiometry-dependent effect on breast cancer cell line apoptosis upon receptor activation.</p>

    oxford Repository record for Extending the scope of covalent peptide-protein conjugation: from purification to expanded nanoassembly (opens in a new tab)

  17. Conformational Dynamics Associated with Signaling in Tumor Necrosis Factor Receptors

    The long accepted model for tumor necrosis factor receptor (TNFR) signaling is that ligand binding causes receptors to trimerize, resulting in a stoichiometric change in their cytosolic domains. This model is incomplete in that it does not explain the importance of receptor self-interaction nor …

    umn Repository record for Conformational Dynamics Associated with Signaling in Tumor Necrosis Factor Receptors (opens in a new tab)

  18. The Anti-Tumor Effects Of Hur Inhibition In Glioblastoma

    … produces a dose-dependent toxicity through the death receptor 5 (DR5) pathway, a decrease in GSC frequency, attenuation of cell migration at sublethal doses and inhibited expression of key growth factors and cytokines. In the second part of the project, we generated a tissue specific HuR …

    uab Repository record for The Anti-Tumor Effects Of Hur Inhibition In Glioblastoma (opens in a new tab)

Page 1 of 2